CTS Corporation

there'll be an opportunity to ask questions. If you'd like to ask a question, you can do so by pressing star followed by one on your telephone keypad. I'll now hand you over to Kieran O'Sullivan, CEO, to begin. Please go ahead.

Thank you, Lydia. Good morning and thank you for joining our first quarter 2024 earnings call. Sales were in line with our expectations for the quarter as non-transportation sales started to stabilize from the ongoing reduction in customer inventory. In the quarter, we also saw an improved booking trend for non-transportation markets. Sales to commercial vehicle markets declined as expected, driven by softer demand and a more competitive environment. Light vehicle sales were stable across most regions except in China, where our sales to transplant OEMs were softer. While defense sales were lower due primarily to the timing of shipments, We expect good momentum for the rest of 2024. Across medical, we saw solid performance. Ashish, our CFO, will take us to the safe harbor statement.

Ashish? I would like to remind our listeners that this conference call contains forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Additional information regarding these risks and uncertainties is contained in the press release issued today, and more information can be found in the company's SEC filings. To the extent that today's discussion refers to any non-GAAP measures under Regulation G, the required explanations and reconciliations are available with today's earnings press release and supplemental slide presentation, which can be found in the investor's section of the CTS website. I'll now turn the discussion back over to our CEO, Kiran O'Sullivan.